Treatment of central nervous system manifestations in mitochondrial disorders
Identifieur interne : 000111 ( Main/Exploration ); précédent : 000110; suivant : 000112Treatment of central nervous system manifestations in mitochondrial disorders
Auteurs : J. FinstererSource :
- European Journal of Neurology [ 1351-5101 ] ; 2011-01.
English descriptors
- KwdEn :
Abstract
Central nervous system (CNS) manifestations of mitochondrial disorders (MIDs) are accessible to therapy. Therapy of CNS abnormalities may be categorized as acting on the pathogenic cascade or on the genetic level, which is experimental. Treatment acting on the pathogenic cascade may be classified as non‐specific, including antioxidants, electron donors/acceptors, lactate‐lowering agents, alternative energy providers, cofactors, avoidance of mitochondrion‐toxic drugs, and physiotherapy, or as specific, including drugs against epilepsy, movement disorders, migraine, spasticity, psychiatric abnormalities, hypopituitarism, or bulbar manifestations, ketogenic diet, deep brain stimulation, or artificial ventilation. Stroke‐like episodes need to be delineated from ischaemic stroke and require special management. Potentially, mitochondrion‐toxic drugs and drug cocktails need to be avoided, seizures should be consequently treated even with mitochondrion‐toxic drugs if necessary, and as few drugs as possible should be given. Effective treatment acting on the pathogenic cascade may increase the quality of life and outcome in patients with MID and may prevent a therapeutic nihilism occasionally upcoming with MIDs.
Url:
DOI: 10.1111/j.1468-1331.2010.03086.x
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment of central nervous system manifestations in mitochondrial disorders</title><author><name sortKey="Finsterer, J" sort="Finsterer, J" uniqKey="Finsterer J" first="J." last="Finsterer">J. Finsterer</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:2E85B6ECCA197787BC954B139C0EBEB0CE7932E2</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1111/j.1468-1331.2010.03086.x</idno><idno type="url">https://api.istex.fr/document/2E85B6ECCA197787BC954B139C0EBEB0CE7932E2/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002C38</idno><idno type="wicri:Area/Main/Curation">002869</idno><idno type="wicri:Area/Main/Exploration">000111</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Treatment of central nervous system manifestations in mitochondrial disorders</title><author><name sortKey="Finsterer, J" sort="Finsterer, J" uniqKey="Finsterer J" first="J." last="Finsterer">J. Finsterer</name><affiliation><wicri:noCountry code="subField">Europe</wicri:noCountry></affiliation></author></analytic><monogr></monogr><series><title level="j">European Journal of Neurology</title><idno type="ISSN">1351-5101</idno><idno type="eISSN">1468-1331</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2011-01">2011-01</date><biblScope unit="volume">18</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="28">28</biblScope><biblScope unit="page" to="38">38</biblScope></imprint><idno type="ISSN">1351-5101</idno></series><idno type="istex">2E85B6ECCA197787BC954B139C0EBEB0CE7932E2</idno><idno type="DOI">10.1111/j.1468-1331.2010.03086.x</idno><idno type="ArticleID">ENE3086</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1351-5101</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>brain</term><term>cerebrum</term><term>encephalomyopathy</term><term>mitochondrial cytopathy</term><term>mitochondriopathy</term><term>multi‐system disease</term><term>oxidative phosphorylation</term><term>respiratory chain</term><term>spinal cord</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Central nervous system (CNS) manifestations of mitochondrial disorders (MIDs) are accessible to therapy. Therapy of CNS abnormalities may be categorized as acting on the pathogenic cascade or on the genetic level, which is experimental. Treatment acting on the pathogenic cascade may be classified as non‐specific, including antioxidants, electron donors/acceptors, lactate‐lowering agents, alternative energy providers, cofactors, avoidance of mitochondrion‐toxic drugs, and physiotherapy, or as specific, including drugs against epilepsy, movement disorders, migraine, spasticity, psychiatric abnormalities, hypopituitarism, or bulbar manifestations, ketogenic diet, deep brain stimulation, or artificial ventilation. Stroke‐like episodes need to be delineated from ischaemic stroke and require special management. Potentially, mitochondrion‐toxic drugs and drug cocktails need to be avoided, seizures should be consequently treated even with mitochondrion‐toxic drugs if necessary, and as few drugs as possible should be given. Effective treatment acting on the pathogenic cascade may increase the quality of life and outcome in patients with MID and may prevent a therapeutic nihilism occasionally upcoming with MIDs.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Finsterer, J" sort="Finsterer, J" uniqKey="Finsterer J" first="J." last="Finsterer">J. Finsterer</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000111 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000111 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:2E85B6ECCA197787BC954B139C0EBEB0CE7932E2
|texte= Treatment of central nervous system manifestations in mitochondrial disorders
}}
| This area was generated with Dilib version V0.6.23. |  |